These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 17158536)
41. Association between large-scale genomic homozygosity without chromosomal loss and nonseminomatous germ cell tumor development. Lu YJ; Yang J; Noel E; Skoulakis S; Chaplin T; Raghavan M; Purkis T; McIntyre A; Kudahetti SC; Naase M; Berney D; Shipley J; Oliver RT; Young BD Cancer Res; 2005 Oct; 65(20):9137-41. PubMed ID: 16230368 [TBL] [Abstract][Full Text] [Related]
42. Poor-prognosis germ cell tumors: we have not yet crossed the finish line. Vaughn DJ; Stadtmauer EA J Clin Oncol; 2007 Jan; 25(3):239-40. PubMed ID: 17235039 [No Abstract] [Full Text] [Related]
43. [Analysis of gene expression of human tumor cells in testicular tumor]. Niclas C; Sparwasser C Urologe A; 2007 Sep; 46(9):1185. PubMed ID: 17690861 [No Abstract] [Full Text] [Related]
44. Comparative proteome, transcriptome, and genome analysis of a gonadal and an extragonadal germ cell tumor cell line. Glaesener S; Honecker F; Veltman IM; Gillis AJ; Rohlfing T; Streichert T; Otto B; Brummendorf TH; Looijenga LH; Bokemeyer C; Balabanov S J Proteome Res; 2008 Sep; 7(9):3890-9. PubMed ID: 18642941 [TBL] [Abstract][Full Text] [Related]
45. From embryonic stem cells to testicular germ cell cancer-- should we be concerned? Almstrup K; Sonne SB; Hoei-Hansen CE; Ottesen AM; Nielsen JE; Skakkebaek NE; Leffers H; Rajpert-De Meyts E Int J Androl; 2006 Feb; 29(1):211-8. PubMed ID: 16466542 [TBL] [Abstract][Full Text] [Related]
46. Chromosome 3p25.3 Gain Is Associated With Cisplatin Resistance and Is an Independent Predictor of Poor Outcome in Male Malignant Germ Cell Tumors. Timmerman DM; Eleveld TF; Sriram S; Dorssers LCJ; Gillis AJM; Schmidtova S; Kalavska K; van de Werken HJG; Oing C; Honecker F; Mego M; Looijenga LHJ J Clin Oncol; 2022 Sep; 40(26):3077-3087. PubMed ID: 35442716 [TBL] [Abstract][Full Text] [Related]
47. Cytogenetics of male germ-cell tumors. Chaganti RS; Rodriguez E; Bosl GJ Urol Clin North Am; 1993 Feb; 20(1):55-66. PubMed ID: 8381998 [TBL] [Abstract][Full Text] [Related]
48. First-line chemotherapy of non-seminomatous germ cell tumors(NSGCTs). Pliarchopoulou K; Pectasides D Cancer Treat Rev; 2009 Nov; 35(7):563-9. PubMed ID: 19576697 [TBL] [Abstract][Full Text] [Related]
49. Molecular portrait of cisplatin induced response in human testis cancer cell lines based on gene expression profiles. Duale N; Lindeman B; Komada M; Olsen AK; Andreassen A; Soderlund EJ; Brunborg G Mol Cancer; 2007 Aug; 6():53. PubMed ID: 17711579 [TBL] [Abstract][Full Text] [Related]
50. Expression of glypican 3 in ovarian and extragonadal germ cell tumors. Zynger DL; Everton MJ; Dimov ND; Chou PM; Yang XJ Am J Clin Pathol; 2008 Aug; 130(2):224-30. PubMed ID: 18628091 [TBL] [Abstract][Full Text] [Related]
51. Phase I/II study of sequential dose-intensified ifosfamide, cisplatin, and etoposide plus paclitaxel as induction chemotherapy for poor prognosis germ cell tumors by the German Testicular Cancer Study Group. Hartmann JT; Gauler T; Metzner B; Gerl A; Casper J; Rick O; Horger M; Schleicher J; Derigs G; Mayer-Steinacker R; Beyer J; Kuczyk MA; Bokemeyer C; J Clin Oncol; 2007 Dec; 25(36):5742-7. PubMed ID: 18089869 [TBL] [Abstract][Full Text] [Related]
52. Role of N-cadherin in proliferation, migration, and invasion of germ cell tumours. Bremmer F; Schallenberg S; Jarry H; Küffer S; Kaulfuss S; Burfeind P; Strauß A; Thelen P; Radzun HJ; Ströbel P; Honecker F; Behnes CL Oncotarget; 2015 Oct; 6(32):33426-37. PubMed ID: 26451610 [TBL] [Abstract][Full Text] [Related]